SCHEMBL3500748

SCHEMBL3500748

COC(=O)Nc1ccc2[nH]c(-c3cscn3)nc2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 8/20 0.52
METAP2 P50579 5/20 0.51
KDM4E B2RXH2 3/20 0.51
NPC1 O15118 2/20 0.51
TP53 P04637 2/20 0.51
RAB9A P51151 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
ADORA3 P0DMS8 1/20 0.51
CYP2D6 P10635 1/20 0.51
TSHR P16473 1/20 0.51
CYP2C19 P33261 1/20 0.51
FKBP1A P62942 1/20 0.51
HIF1A Q16665 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3500750 0.91 METAP1 (0.59) METAP1METAP2KDM4ENPC1TP53
Cambendazole SCHEMBL44000 0.89 METAP1 (0.48) METAP1METAP2KDM4ENPC1TP53
Cambendazole SCHEMBL29409263 0.89 METAP1 (0.48) METAP1METAP2KDM4ENPC1TP53
SCHEMBL11208569 0.87 METAP1 (0.55) METAP1METAP2KDM4ENPC1TP53
SCHEMBL4367616 0.86 MAPT (0.51) METAP1METAP2KDM4ENPC1TP53
Cambendazole SCHEMBL8734398 0.85 METAP1 (0.57) METAP1METAP2KDM4ENPC1TP53
SCHEMBL4376877 0.83 METAP1 (0.48) METAP1METAP2KDM4ENPC1TP53
SCHEMBL4372948 0.82 KDR (0.57) KDM4ENPC1SMN1; SMN2TDP1ALDH1A1
SCHEMBL4380005 0.81 METAP1 (0.53) METAP1METAP2KDM4ENPC1TP53
SCHEMBL4368907 0.81 MAPT (0.55) METAP1METAP2KDM4ENPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160369237-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY ADVANCED CELL TECH INC (US) 2016-12-22 US disclosed
US-20100184033-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY Lineage Cell Therapeutics, Inc. 2010-07-22 US disclosed
US-20080226601-A1 Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods UNIVERSITY OF ROCHESTER (US) 2008-09-18 US disclosed
US-20080070303-A1 Using myocardial and/or muscle progenitor cells as modeling tool in tissue engineering; regenerative medicine and organ replacement ADVANCED CELL TECHNOLOGY 2008-03-20 US disclosed
WO-2007062198-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY ADVANCED CELL TECHNOLOGY, INC. (US) 2007-05-31 WO disclosed